Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Sullivan

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Hypertension (Dallas, Tex. : 1979)|June 25, 2014
Effect of periodontal therapy on arterial structure and function among aboriginal australians: a randomized, controlled trialKostas Kapellas, Louise J Maple-Brown, Lisa M Jamieson, et al.
Australian Journal of General Practice|August 31, 2021
Awareness of familial hypercholesterolaemia in Australian primary care: A qualitative descriptive studyCaroline Bulsara, Tom Brett, Jan Radford, et al.
Proteomics. Clinical Applications|March 9, 2023
Optimised plasma sample preparation and LC-MS analysis to support large-scale proteomic analysis of clinical trial specimens: Application to the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trialMatthew B O'Rourke, Andrzej S Januszewski, David R Sullivan, et al.
Circulation|January 26, 2018
D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID StudyJohn Simes, Kristy P Robledo, Harvey D White, et al.
Australian Journal of General Practice|July 31, 2022
Cost impact of undertaking detection and management of familial hypercholesterolaemia in Australian general practiceIan W Li, Rory Watts, Tom Brett, et al.
Diabetes & Vascular Disease Research|July 19, 2021
The relationship of neutrophil elastase and proteinase 3 with risk factors, and chronic complications in type 2 diabetes: A Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) sub-studyKwok-Leung Ong, Liang Wu, Andrzej S Januszewski, et al.
Heart (British Cardiac Society)|May 21, 2021
Improving detection and management of familial hypercholesterolaemia in Australian general practiceTom Brett, Dick C Chan, Jan Radford, et al.
Journal of the American Heart Association|October 25, 2013
Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease studyHarvey D White, John Simes, Ralph A H Stewart, et al.
Scientific Reports|September 22, 2021
Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetesAndrzej S Januszewski, David Chen, Russell S Scott, et al.
Heart, Lung & Circulation|December 14, 2020
Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in AustraliaGerald F Watts, David R Sullivan, David L Hare, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Hypertension (Dallas, Tex. : 1979)|June 25, 2014
Effect of periodontal therapy on arterial structure and function among aboriginal australians: a randomized, controlled trialKostas Kapellas, Louise J Maple-Brown, Lisa M Jamieson, et al.
Australian Journal of General Practice|August 31, 2021
Awareness of familial hypercholesterolaemia in Australian primary care: A qualitative descriptive studyCaroline Bulsara, Tom Brett, Jan Radford, et al.
Proteomics. Clinical Applications|March 9, 2023
Optimised plasma sample preparation and LC-MS analysis to support large-scale proteomic analysis of clinical trial specimens: Application to the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trialMatthew B O'Rourke, Andrzej S Januszewski, David R Sullivan, et al.
Circulation|January 26, 2018
D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID StudyJohn Simes, Kristy P Robledo, Harvey D White, et al.
Australian Journal of General Practice|July 31, 2022
Cost impact of undertaking detection and management of familial hypercholesterolaemia in Australian general practiceIan W Li, Rory Watts, Tom Brett, et al.
Diabetes & Vascular Disease Research|July 19, 2021
The relationship of neutrophil elastase and proteinase 3 with risk factors, and chronic complications in type 2 diabetes: A Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) sub-studyKwok-Leung Ong, Liang Wu, Andrzej S Januszewski, et al.
Heart (British Cardiac Society)|May 21, 2021
Improving detection and management of familial hypercholesterolaemia in Australian general practiceTom Brett, Dick C Chan, Jan Radford, et al.
Journal of the American Heart Association|October 25, 2013
Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease studyHarvey D White, John Simes, Ralph A H Stewart, et al.
Scientific Reports|September 22, 2021
Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetesAndrzej S Januszewski, David Chen, Russell S Scott, et al.
Heart, Lung & Circulation|December 14, 2020
Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in AustraliaGerald F Watts, David R Sullivan, David L Hare, et al.
Pageof 11